TLX — TELIX PHARMACEUTICAL LTD
As of Q2 2026, 9 SEC-registered investment managers reported holding TLX (TELIX PHARMACEUTICAL LTD) in their latest 13F filings, with a combined reported value of $16.53M across 1.44M shares. That is +41.6% by share count (+421.33K shares) versus the previous quarter, while reported value moved +70.4%. Ownership is concentrated: the five largest holders account for 93.1% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 4 added to existing stakes, 2 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
TLX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 561.21K | $6.47M | 0.00% | Reduce |
| Lazard Asset Management history | Q2 2026 | 284.21K | $3.28M | 0.01% | Reduce |
| Marshall Wace history | Q2 2026 | 189.19K | $2.18M | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 165.98K | $1.91M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 134.70K | $1.55M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 77.54K | $876.18K | 0.00% | New |
| Citadel Advisors history | Q4 2025 | 23.00K | $172.25K | 0.00% | New |
| Millennium Management history | Q4 2025 | 19.73K | $147.80K | 0.00% | Reduce |
| Point72 Asset Management history | Q4 2025 | 18.41K | $137.88K | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 11.02K | $127.04K | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 10.23K | $117.99K | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 1.06K | $12.22K | 0.00% | Add |
New Positions (Q2 2026)
- Marshall Wace 189.19K sh · $2.18M
- JPMorgan Chase & Co 77.54K sh · $876.18K
- Two Sigma Investments 10.23K sh · $117.99K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 12 funds)
| Fund | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | — | — | 42.09K | 118.48K | 123.57K | 564.76K | 561.21K |
| Lazard Asset Management | — | — | — | 114.62K | 250.52K | 289.92K | 284.21K |
| Marshall Wace | — | — | — | 48.57K | 46.66K | — | 189.19K |
| Morgan Stanley | — | 5.63K | 4.40K | 3.23K | 17.65K | 116.44K | 165.98K |
| UBS Group AG | 3.73K | 3.65K | 6.12K | 5.57K | 1.96K | 32.30K | 134.70K |
| JPMorgan Chase & Co | — | — | — | 25.36K | 74.37K | — | 77.54K |
| Bank of America Corp | — | — | — | 2.15K | 1.61K | 10.03K | 11.02K |
| Two Sigma Investments | — | — | — | — | — | — | 10.23K |
| BlackRock Inc | — | — | — | — | 88 | 352 | 1.06K |
| Citadel Advisors | — | — | 41.33K | — | 23.00K | — | — |
| Point72 Asset Management | — | — | — | — | 18.41K | — | — |
| Millennium Management | — | — | — | 196.74K | 19.73K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details